Medical/Pharmaceuticals

Vexev's VxWave System Successfully Meets Clinical Endpoints in Landmark Study Evaluating Robotic Ultrasound Scanning for Mapping Vascular Access at U.S. Renal Care Dialysis Clinics

* VxWave Ultrasound Imaging System demonstrated 94% scanning success rate and 100% data adequacy rate for vascular access creation strategies in CANSCAN trial * New insights into vascular anatomy made possible by standardized image acquisition and reporting * VxWave System has the potential t...

2025-11-11 05:32 1378

TraceLink Customers Demonstrate Readiness as DSCSA Dispenser Deadline Arrives

TraceLink Continues to Set the Standard for United States Drug Supply Chain Security (DSCSA) Leadership, Proven by Real-World Success, Industry Adoption, and Superior Service BOSTON, Nov. 10, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestr...

2025-11-10 23:00 1206

Brii Biosciences Presents Late-Breaking Data from Ongoing Phase 2 ENSURE Study at AASLD 2025, Reinforcing BRII-179's Potential as a Curative Treatment for Chronic Hepatitis B

* Cohort 4 follow-up confirms durable hepatitis B surface antigen (HBsAg) loss at 24 weeks post end of treatment (EOT) in BRII-179 anti-HBs responders treated with elebsiran plus pegylated interferon alfa (PEG-IFNα) * Data suggest the potential to shorten PEG-IFNα treatment duration for BRII-...

2025-11-10 21:30 2534

Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting

- Data demonstrates ofirnoflast's efficacy in myelodysplastic syndrome (MDS) with robust and sustained hematologic responses – - A novel mechanism targeting NEK7 and NLRP3 inflammasomes shows promise across multiple myeloid neoplasms – - Preclinical data reveal potential applications in hemolyti...

2025-11-10 21:15 1188

MediTrust Health and Sino Biopharm Sign Strategic Cooperation Agreement at CIIE 2025 to Advance Drug-Insurance Integration New Model

HONG KONG, Nov. 10, 2025 /PRNewswire/ -- Shanghai, November 10, 2025 – During the 8th China International Import Expo (CIIE), Sino Biopharmaceutical Limited ("Sino Biopharm") and Shanghai MediTrust Health Technology Group Co., Ltd. ("M ediTrustHealth") signed a strategic cooperation agreement. The...

2025-11-10 14:18 1339

Rona Therapeutics Presents Phase 1 Data for RN0361, a Long-Acting APOC3-Targeting siRNA, at the American Heart Association 2025 Scientific Sessions

NEW ORLEANS, Nov. 10, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, presented highlights of Phase 1 clinical data for RN0361, a long-acting Apolipoprotein C3 (ApoC3) siRNA. RN0361 achieved potent, durable reductions in ApoC3 and triglycer...

2025-11-10 12:00 2077

Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotecan Results From Multiple Clinical Studies at the 2025 CCHIO Congress

CHENGDU, China, Nov. 10, 2025 /PRNewswire/ -- From November 6 to 9, the 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) was held in Kunming, Yunnan. This conference was jointly organized by the Chinese Anti-Cancer Association (CACA), the Tengchong Science Forum Organizing Committee ...

2025-11-10 10:01 1730

ICP DAS-BMP Attends MOU Signing Ceremony to Mark a New Milestone in Medical-Grade TPU Materials

HSINCHU, Nov. 10, 2025 /PRNewswire/ -- ICP DAS-BMP participated in the Strategic Memorandum of Understanding (MOU) signing ceremony organized by Towards Buddha Co., Ltd. onOctober 28, where it showcased its R&D achievements and diverse applications in medical-grade TPU materials. Moving forward, ...

2025-11-10 08:45 1404

2025 Aurora Prize for Awakening Humanity Awarded to Dr. Jamal Eltaeb

Head of Al Nao Hospital in Sudan recognized for sustaining critical medical care amid civil war and saving hundreds of lives NEW YORK, Nov. 8, 2025 /PRNewswire/ -- The Aurora Humanitarian Initiative announced Thursday evening thatDr. Jamal Eltaeb

2025-11-08 00:03 766

Brii Biosciences Announces Publication of Phase 2 ENSURE Study Results in Nature Medicine

* Findings provide scientific insights into the contribution of small interfering RNA (siRNA) and therapeutic vaccination towards the HBV functional cure strategy DURHAM, N.C. and BEIJING, Nov. 7, 2025 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio," or the "Com...

2025-11-07 21:30 1955

EBR Systems Achieves First Enrollments in the WiSE-UP Study for Heart Failure Patients

The WiSE-UP post-approval study is gathering real-world evidence from commercially treated patients using the WiSE® left ventricular endocardial pacing (LVEP) system. Key Highlights: * The first two patients have now been enrolled in the WiSE-UP post-approval study by DrDevi Nair from St Bern...

2025-11-07 21:00 1112

Cranial Technologies Debuts NMPA-Cleared Infant Head Reshaping Treatment in China at CIIE

SHANGHAI, Nov. 7, 2025 /PRNewswire/ -- Cranial Technologies, a leading US medical device company specializing in the treatment of infant head shape conditions, officially introduced its flagship DOC Band® treatment in the Chinese market at the China International Import Expo (CIIE), taking place ...

2025-11-07 15:58 1188

Fosun International Honored with Gold Award and Best Sustainability Team at The Asset Corporate Sustainability Leadership Awards 2025

HONG KONG, Nov. 7, 2025 /PRNewswire/ -- On the evening of 6 November 2025, The Asset, a renowned Asian financial magazine, hosted "The Asset Corporate Sustainability Leadership Awards 2025" ceremony inSingapore. Fosun International Limited ("Fosun International" or the "Company") (HKEX stock cod...

2025-11-07 09:00 3354

Australian Sleep Tech Company Launches a Smart Ring to Transform Sleep & Health - retimer Ring

ADELAIDE, Australia, Nov. 7, 2025 /PRNewswire/ -- Re-Time Pty Ltd (RTPL) today announced the launch of the retimer Ring, the first smart ring solution developed by an Australian company to help people improve sleep and overall wellbeing. Building on a legacy of more than 25 years of research at F...

2025-11-07 07:00 1518

Leading Fertility Specialist Associate Professor Gavin Sacks joins Genea

SYDNEY, Nov. 6, 2025 /PRNewswire/ -- Genea Fertility, Australia's pioneering fertility network, is pleased to announce the appointment of internationally renowned fertility specialist, Associate ProfessorGavin Sacks, to its medical leadership team, continuing the organisation's 40-year tradition ...

2025-11-06 16:09 1143

Fosun Marks Eighth Year at CIIE, Guo Guangchang Calls for More Cutting-Edge Innovation

HONG KONG, Nov. 6, 2025 /PRNewswire/ -- On 5 November 2025, the 8th China International Import Expo (CIIE) opened at the National Exhibition and Convention Center (Shanghai). As a "full-attendance" exhibitor for eight consecutive years, Fosun, together with its overseas member companies and glob...

2025-11-06 15:19 2539

Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy

Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines". LOS ANGELES, Nov. 6, 2025 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific breakthro...

2025-11-06 14:11 1302

THE ADECCO GROUP Q3 2025 RESULTS

AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange Strong share gains, good growth and improved profit margin ZURICH, Nov. 6, 2025 /PRNewswire/ --   HIGHLIGHTS * Further strong market share gains, Group +375 bps and Adecco +300 bps * Group revenues +3.4% yoy, and +3...

2025-11-06 13:45 961

Alphamab Oncology Showcases Cutting-edge Breakthroughs and Innovative Achievements at the 16th World ADC San Diego

SUZHOU, China, Nov. 6, 2025 /PRNewswire/ -- The 16th World ADC San Diego, held from November 3–6, 2025, brought together industry leaders inSan Diego, USA. Dr. Ting Xu, Founder, Chairman, and CEO of Alphamab Oncology, was invited to deliver a presentation titled "JSKN021: EGFR/HER3 Targeted Dual-...

2025-11-06 12:05 1173

New Regional Certifications to Boost Healthcare Training Standards Across Southeast Asia

* Two new specially designed certification programmes will train doctors, nurses and technical specialists across the region in simulation-based medical education. SINGAPORE, Nov. 6, 2025 /PRNewswire/ -- The first healthcare simulation certification programmes designed specifically for Southeas...

2025-11-06 10:13 1096
1 ... 13141516171819 ... 396